KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Cash & Current Investments (2016 - 2025)

Jazz Pharmaceuticals has reported Cash & Current Investments over the past 16 years, most recently at $1.4 billion for Q4 2025.

  • Quarterly Cash & Current Investments fell 42.31% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, down 42.31% year-over-year, with the annual reading at $1.4 billion for FY2025, 42.31% down from the prior year.
  • Cash & Current Investments was $1.4 billion for Q4 2025 at Jazz Pharmaceuticals, up from $1.3 billion in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $2.4 billion in Q4 2024 and troughed at $490.8 million in Q1 2022.
  • The 5-year median for Cash & Current Investments is $1.3 billion (2023), against an average of $1.3 billion.
  • Biggest five-year swings in Cash & Current Investments: surged 198.96% in 2021 and later crashed 76.6% in 2022.
  • Tracing JAZZ's Cash & Current Investments over 5 years: stood at $591.4 million in 2021, then skyrocketed by 49.04% to $881.5 million in 2022, then surged by 70.88% to $1.5 billion in 2023, then skyrocketed by 60.18% to $2.4 billion in 2024, then crashed by 42.31% to $1.4 billion in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $1.4 billion, $1.3 billion, and $1.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.